Abstract
A study was conducted in Barkin Ladi on the North Central plateau of Nigeria to assess the efficacy and tolerability of a single-dose (10 mg/kg) amodiaquine co-administered with sulfadoxine/pyrimethamine (SP) against Plasmodium falciparum malaria in children less than 5 years of age using a 14-day protocol. The combination was highly efficacious in 41 patients involved in the trial, producing rapid parasite clearance (MPCR= 2.73 days) and faster clearance of fever (MFCR= 1.2 days). Adequate clinical and parasitological response (ACPR) achieved was 97.6%, while there was 1 (2.4%) case of late parasitological failure (LPF). The single-dose combination produced a significant improvement in PCV (p
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
